ResearcherUniversity Hospital of LarissaActive in the last 2 years
Dimitris Zacharoulis
Matched on ORCID iD 0000-0002-8972-064X; OpenAlex author ID A5039213604, A5113892843. Sources: ClinicalTrials.gov.
Their work
- Papers
- 9 (first author 0, last author 5)
- Trials
- 1
- Grants
- 0
- Labs led
- 1
- Collaborators
- 13
2018: 1 paper · 2019: 1 paper · 2020: none · 2021: 2 papers, 1 trial · 2022: 3 papers · 2023: 1 paper · 2024: none · 2025: 1 paper
Papers 9
- Venous thromboembolism in patients undergoing pancreatic cancer surgery (PaTR-VTE) with curative intent; protocol of a prospective observational study. Co-author DOI 10.1186/s12893-024-02665-z↗
- Validation of the Surgical Outcome Risk Tool (SORT) and SORT v2 for Predicting Postoperative Mortality in Patients with Pancreatic Cancer Undergoing Surgery. Last author DOI 10.3390/jcm12062327↗
- A meta-analysis evaluating the role of high-intensity focused ultrasound (HIFU) as a fourth treatment modality for patients with locally advanced pancreatic ca… Last author DOI 10.1007/s00261-021-03334-y↗
- Establishment of Patient-derived Orthotopic Xenografts (PDX) as Models for Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.21873/invivo.12809↗
- Bioinformatic Analysis of the BCL-xL/BCL2L1 Interactome in Patients with Pancreatic Cancer. Co-author DOI 10.3390/medicina58111663↗
- Validation of the Surgical Outcome Risk Tool (SORT) in patients with pancreatic cancer undergoing surgery. Last author DOI 10.1016/j.bjane.2020.10.018↗
- The surgical challenge of oligometastatic pancreatic cancer: A systemic review of the literature. Last author PMID 34761577↗
- Transcriptomic analysis of the Aquaporin (AQP) gene family interactome identifies a molecular panel of four prognostic markers in patients with pancreatic duct… Last author DOI 10.1016/j.pan.2019.02.006↗
- Radiofrequency assisted pancreaticoduodenectomy for palliative surgical resection of locally advanced pancreatic adenocarcinoma. Co-author DOI 10.18632/oncotarget.24596↗
Trials 1
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Dimitrios E. Magouliotis · 7 shared papers, 2019–2023 · strength 1.10
- Paper Validation of the Surgical Outcome Risk Tool (SORT) and SORT v2 for Predicting Postoperative Mortality in Patients with… DOI 10.3390/jcm12062327↗
- Paper Establishment of Patient-derived Orthotopic Xenografts (PDX) as Models for Pancreatic Ductal Adenocarcinoma. DOI 10.21873/invivo.12809↗
- Paper Validation of the Surgical Outcome Risk Tool (SORT) in patients with pancreatic cancer undergoing surgery. DOI 10.1016/j.bjane.2020.10.018↗
- Maria P. Fergadi · 3 shared papers, 2021–2023 · strength 0.52
- Paper Validation of the Surgical Outcome Risk Tool (SORT) and SORT v2 for Predicting Postoperative Mortality in Patients with… DOI 10.3390/jcm12062327↗
- Paper Validation of the Surgical Outcome Risk Tool (SORT) in patients with pancreatic cancer undergoing surgery. DOI 10.1016/j.bjane.2020.10.018↗
- Paper A meta-analysis evaluating the role of high-intensity focused ultrasound (HIFU) as a fourth treatment modality for pati… DOI 10.1007/s00261-021-03334-y↗
- Dimitrios Symeonidis · 2 shared papers, 2021–2025 · strength 0.44
- Paper Venous thromboembolism in patients undergoing pancreatic cancer surgery (PaTR-VTE) with curative intent; protocol of a … DOI 10.1186/s12893-024-02665-z↗
- Paper Validation of the Surgical Outcome Risk Tool (SORT) in patients with pancreatic cancer undergoing surgery. DOI 10.1016/j.bjane.2020.10.018↗
- Konstantinos S. Dimas · 3 shared papers, 2019–2022 · strength 0.43
- Paper Establishment of Patient-derived Orthotopic Xenografts (PDX) as Models for Pancreatic Ductal Adenocarcinoma. DOI 10.21873/invivo.12809↗
- Paper Bioinformatic Analysis of the BCL-xL/BCL2L1 Interactome in Patients with Pancreatic Cancer. DOI 10.3390/medicina58111663↗
- Paper Transcriptomic analysis of the Aquaporin (AQP) gene family interactome identifies a molecular panel of four prognostic … DOI 10.1016/j.pan.2019.02.006↗
- Anna P. Karamolegkou · 2 shared papers, 2022–2023 · strength 0.34
- Eleni M. Arnaoutoglou · 1 shared paper, 2025 · strength 0.27
- Maria P. Ntalouka · 1 shared paper, 2025 · strength 0.27
- Gregory Christodoulidis · 1 shared paper, 2021 · strength 0.15
- Duncan R.C. Spalding · 1 shared paper, 2018 · strength 0.08
- Mikael Hans Sodergren · 1 shared paper, 2018 · strength 0.08
- Kumar Jayant · 1 shared paper, 2018 · strength 0.08
- Isabella Reccia · 1 shared paper, 2018 · strength 0.08
- Nagy Adley Habib · 1 shared paper, 2018 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.